共 50 条
- [1] Endothelial progenitor cells are decreased in the peripheral blood of patients suffering from rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S524 - S524
- [2] A potential role for endothelial progenitor cells in synovial neovascularization of rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S49 - S50
- [3] Cardiovascular risk factors and rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S707 - S707
- [4] Hyperuricemia As a Risk Factor for Cardiovascular Disease in Patients With Rheumatoid Arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S158 - S158
- [5] Risk factors for cardiovascular disease in Chilean patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S153 - S153
- [6] Cardiovascular risk in rheumatoid arthritis. Untill where? [J]. REUMATOLOGIA CLINICA, 2006, 2 (05): : 221 - 223
- [8] Functional Role of Chondrogenic Progenitor Cells in Rheumatoid Arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S517 - S517
- [9] Infliximab increases levels of circulating endothelial progenitor cells (EPCs) and improves their functional properties in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S581 - S581